Showing results (881-890 of 917) with videos related to

Sort By:
Pageof 92
British Journal of Cancer|December 15, 2023
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world studyClémence Flecchia, Edouard Auclin, Emily Alouani, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2026
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): Results from the GASPAR phase 2 studyMélanie Dos Santos, Justine Lequesne, Guillaume Piessen, et al.
Journal for Immunotherapy of Cancer|October 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world studyEmily Alouani, Julien Taieb, David Tougeron, et al.
ESMO Open|May 27, 2023
Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO studyE Alouani, M Mercier, C Flecchia, et al.
JACC. Cardiovascular Imaging|September 11, 2020
Proposed Requirements for Cardiovascular Imaging-Related Machine Learning Evaluation (PRIME): A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation CouncilPartho P Sengupta, Sirish Shrestha, Béatrice Berthon, et al.
Critical Care Medicine|June 26, 2015
Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac ArrestMatthias Kohlhauer, Fanny Lidouren, Isabelle Remy-Jouet, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2025
Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO studyIona Campo-Le-Brun, Emma Grapinet, Valerie Aurillac, et al.
Nature Medicine|April 14, 2026
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trialDevalingam Mahalingam, Rachna T Shroff, Benedito A Carneiro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studiesMorgane Stouvenot, Aurélia Meurisse, Angélique Saint, et al.
The Lancet. Oncology|July 26, 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 studyStefano Kim, Eric François, Thierry André, et al.
Pageof 92